Todd Young serves as Executive Vice President and Chief Financial Officer, a position he has held since he joined Elanco in November 2018. Todd oversees our financial operations, including treasury, investor relations and tax functions, information technology and transformation. He brings significant financial leadership experience in pharmaceutical and healthcare as well as a focus on strategic and commercial decision-making to his position.

Prior to joining Elanco, he served as Executive Vice President and Chief Financial Officer at ACADIA Pharmaceuticals Inc., a biopharmaceutical company, from August 2016 to October 2018, where he oversaw their financial functions as well as information technology and facilities. Prior to that, he served in roles of increasing responsibility at Baxter International Inc. and its spin-off company, Baxalta, a biopharmaceutical leader in hematology, immunology and oncology, most recently as Baxalta’s Senior Vice President and Treasurer.

Todd received his bachelor’s degree in Economics from Grinnell College and a Juris Doctor from the University of Michigan.